» Articles » PMID: 6563940

Natural Cytotoxicity of Lymphocytes from Lymph Nodes Draining Breast Carcinoma and Its Augmentation by Interferon and OK432

Overview
Date 1984 Jan 1
PMID 6563940
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphocytes isolated from axillary lymph nodes draining breast carcinoma were tested for natural killer (NK) activity against K562 in a 4-h 51Cr-release assay, and the in vitro effects of interferon (IFN) and OK432 (a streptococcal preparation) on their cytotoxicity were examined in comparison with NK activity of autologous peripheral blood lymphocytes (PBL). The levels of NK activity were lower in lymph node lymphocytes (LNL) than in PBL of the same patients. Significant levels of LNL-mediated lysis were recorded in 14 of 42 (33%) lymph node samples and in nine of 14 (64%) patients. Purification of large granular lymphocytes (LGL) from lymph node cells by discontinuous Percoll density gradient centrifugation resulted in an induction or enhancement of cytotoxic activity, with no reactivity in LGL-depleted, small T-lymphocyte populations. Positive reactions were observed with 10 of 13 (77%) LGL samples. The low reactivity of LNL was not attributable to coexistent suppressor cells for NK function, since lymph node cells failed to suppress NK activity of normal PBL. Partially purified human IFN and OK432 augmented NK activity of patients' PBL in approximately 70% and 90% of the cases, respectively, while LNL-mediated lysis was augmented in only 7% and 36% of the lymph node samples by IFN and OK432, respectively. These results indicate that K562-reactive NK cells and/or their precursors may frequently be present at subthreshold levels in the lymph nodes draining breast carcinoma, and that the augmentation of LNL-mediated cytotoxicity by OK432 might provide a local potentiation of natural immune function at the host-tumor interface rather than IFN.

Citing Articles

Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer.

Zhen Y, Liu X, Yang Y, Li B, Tang J, Zeng Q Cancer Immunol Immunother. 2015; 64(9):1083-93.

PMID: 25990075 PMC: 4540776. DOI: 10.1007/s00262-015-1715-3.


Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients.

Satam M, Suraiya J, Nadkarni J Cancer Immunol Immunother. 1986; 23(1):56-9.

PMID: 3094944 PMC: 11038408. DOI: 10.1007/BF00205556.


The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients.

Yanagawa E, Toge T, Sawamura A, Kegoya Y, Baba N, Hattori T Jpn J Surg. 1988; 18(6):660-7.

PMID: 2977625 DOI: 10.1007/BF02471527.


Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients.

Yanagawa E, Uchida A, Moore M, Micksche M Cancer Immunol Immunother. 1985; 19(3):163-7.

PMID: 2408742 PMC: 11039094. DOI: 10.1007/BF00199221.


Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.

Kusugami K, Matsuura T, Kawase T, Ina K, Matsunaga H, Kuwahara Y Gastroenterol Jpn. 1990; 25(3):306-13.

PMID: 1972685 DOI: 10.1007/BF02779443.


References
1.
Eremin O, Ashby J, STEPHENS J . Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Int J Cancer. 1978; 21(1):35-41. DOI: 10.1002/ijc.2910210108. View

2.
Cunningham-Rundles S, Filippa D, Braun Jr D, Antonelli P, Ashikari H . Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J Natl Cancer Inst. 1981; 67(3):585-90. View

3.
Okamoto H, SHOIN S, Koshimura S, Shimizu R . Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol. 1967; 11(4):323-6. DOI: 10.1111/j.1348-0421.1967.tb00350.x. View

4.
Antonelli P, Stewart 2nd W, DuPont B . Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation. Clin Immunol Immunopathol. 1981; 19(2):161-9. DOI: 10.1016/0090-1229(81)90059-3. View

5.
Hochman P, CUDKOWICZ G . Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice. J Immunol. 1979; 123(3):968-76. View